1. Diagnosis and Molecular Characterization of Nonclassic Forms of Tay-Sachs Disease in Brazil
- Author
-
Lygia da Veiga Pereira, Roberto Giugliani, C. Vasques, M.C. Sá Miranda, Mariz Vainzof, R. Rozenberg, M.G. Burin, Fernando Kok, and A.M.M. Henriques-Souza
- Subjects
Adult ,Pediatrics ,medicine.medical_specialty ,Ataxia ,Genetic counseling ,Disease ,Compound heterozygosity ,03 medical and health sciences ,Hexosaminidase A ,0302 clinical medicine ,Disease Screening ,030225 pediatrics ,Genotype ,medicine ,Humans ,Child ,Genetics ,Tay-Sachs Disease ,business.industry ,Tay-Sachs disease ,medicine.disease ,beta-N-Acetylhexosaminidases ,Pedigree ,Phenotype ,Child, Preschool ,Mutation ,Pediatrics, Perinatology and Child Health ,Spinocerebellar ataxia ,Neurology (clinical) ,medicine.symptom ,business ,Brazil ,030217 neurology & neurosurgery - Abstract
Molecular analysis of five Brazilian families, including eight patients presenting with nonclassic Tay-Sachs disease, was performed to identify frequent causative mutations and their correlation with clinical course. Three patients were affected by the B1 subacute variant and were shown to carry the R178H mutation (the DN allele), which is also common among Portuguese patients. Two of them were compound heterozygotes, whereas the third presented with the mutation in both alleles. Since Brazil was a Portuguese colony for over two centuries, common ancestry might be the probable explanation. The fourth patient presented with a juvenile phenotype and carries the R499H mutation, which has been reported only once worldwide and is associated with residual enzyme activity, responsible for a slower clinical course. The fifth family, of an Ashkenazi Jewish background, showed an extensive intrafamilial clinical variability among three affected sibs presenting with muscle atrophy, ataxia, and psychiatric symptoms. They were first diagnosed as having atypical spinal muscular atrophy and, subsequently, spinocerebellar ataxia, but, recently, the diagnosis of late-onset Tay-Sachs disease was confirmed based on reduced plasma hexosaminidase A activity and the G269S/InsTATC1278 genotype. It is therefore highly recommended to test patients with a similar clinical history for Tay-Sachs disease. In the same family, one first cousin committed suicide at the age of 24 years, presenting with a clinical phenotype that suggested an undiagnosed case and highlighting the effect of the intrafamilial clinical variability in delaying a prompt diagnosis. It is now recognized that his parents are, in fact, a carrier couple. Additionally, another relative had been previously identified as a heterozygote in a Tay-Sachs disease screening program, but the information was not shared among the family. Since this information might anticipate diagnosis and genetic counseling, it is advisable that heterozygote screening programs encourage families to share genetic information. ( J Child Neurol 2006;21:540—544; DOI 10.2310/7010.2006.00102).
- Published
- 2006
- Full Text
- View/download PDF